Abstract
The naturally-occurring alkaloid ibogaine, found in the West African shrub Tabernanthe iboga, possesses the ability to diminish self-administration of substances of abuse, such as cocaine, heroin and alcohol. The presence of the isoquinuclidine ring system in the structure of ibogaine became the lead for the design of a 16-member library of N-aryl isoquinuclidines, where pyridine, pyrimidine and quinoline ring systems were attached directly to the bicyclic nitrogen. A solution-phase method for their synthesis is described.
Keywords: Addiction, Ibogaine, Isoquinuclidine, Parallel synthesis, Anti-addictive
Letters in Drug Design & Discovery
Title: Solution-Phase Parallel Synthesis of N-Arylisoquinuclidines
Volume: 6 Issue: 1
Author(s): Ronald F. Borne, Mark S. Levi, M. O. Faruk Khan and Norman H. Wilson
Affiliation:
Keywords: Addiction, Ibogaine, Isoquinuclidine, Parallel synthesis, Anti-addictive
Abstract: The naturally-occurring alkaloid ibogaine, found in the West African shrub Tabernanthe iboga, possesses the ability to diminish self-administration of substances of abuse, such as cocaine, heroin and alcohol. The presence of the isoquinuclidine ring system in the structure of ibogaine became the lead for the design of a 16-member library of N-aryl isoquinuclidines, where pyridine, pyrimidine and quinoline ring systems were attached directly to the bicyclic nitrogen. A solution-phase method for their synthesis is described.
Export Options
About this article
Cite this article as:
Borne F. Ronald, Levi S. Mark, Faruk Khan O. M. and Wilson H. Norman, Solution-Phase Parallel Synthesis of N-Arylisoquinuclidines, Letters in Drug Design & Discovery 2009; 6 (1) . https://dx.doi.org/10.2174/157018009787158517
DOI https://dx.doi.org/10.2174/157018009787158517 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Modification by Peroxidative Products of Polyunsaturated Fatty Acids
Current Proteomics Activity of γ -Secretase on Substrates Other than APP
Current Topics in Medicinal Chemistry Long-term Treatment with Olanzapine Increases the Number of Sox2 and Doublecortin Expressing Cells in the Adult Subventricular Zone
CNS & Neurological Disorders - Drug Targets Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention
Current Medicinal Chemistry Neuroinflammation and Ageing: Current Theories and an Overview of the Data
Reviews on Recent Clinical Trials Going Local: Insights from EEG and Stereo-EEG Studies of the Human Sleep-Wake Cycle
Current Topics in Medicinal Chemistry Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design Coronary Risk Factors in the Elderly: Their Interactions and Treatment
Current Pharmaceutical Design Targeted Biomedical Treatment for Autism Spectrum Disorders
Current Pharmaceutical Design A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
Mini-Reviews in Medicinal Chemistry Vascular Endothelial Growth Factor and Angiopoietins in Neurovascular Regeneration and Protection Following Stroke
Current Neurovascular Research Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas
Current Pharmaceutical Design Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design Biobanks between Common Good and Private Interest: The Example of Umbilical Cord Blood Private Biobanks
Recent Patents on DNA & Gene Sequences Alzheimer's Disease Prevention and Use of Traditional Plant Medicines
Letters in Drug Design & Discovery Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) ROS Effects on Neurodegeneration in Alzheimers Disease and Related Disorders: On Environmental Stresses of Ionizing Radiation
Current Alzheimer Research A1 Receptors Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders
Current Drug Metabolism Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia
Current Pharmaceutical Design